Trial intelligence / Profile preview

Liposomal iron drops in children with iron deficiency anemia

IRCT20240809062702N1Phase 3Completed

Sponsor
Dr. Abidi Pharmaceuticals
Start
Apr 2024
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, single-arm trial of ferric pyrophosphate liposomal in iron deficiency anemia (IDA), sponsored by Dr. Abidi Pharmaceuticals. Primary endpoints: Change in hemoglobin level, Change in serum iron level and 2 more. Started Apr 2024; status: completed.

02

Drugs

ferric pyrophosphate liposomal
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on IRCT20240809062702N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240809062702N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call